Hageman, SHJ
7  Ergebnisse:
Personensuche X
?
1

Overall benefits of smoking cessation in patients with ASCV..:

Van Trier, T ; Snaterse, M ; Hageman, SHJ...
European Journal of Preventive Cardiology.  29 (2022)  Supplement_1 - p. , 2022
 
?
2

Lifetime versus 10-year risk of recurrent events in patient..:

Van Trier, T ; Snaterse, M ; Hageman, SHJ...
European Journal of Preventive Cardiology.  29 (2022)  Supplement_1 - p. , 2022
 
?
3

Cohort profile: the Utrecht Cardiovascular Cohort-Second Ma..:

Castelijns, MC ; Helmink, MAG ; Hageman, SHJ...
https://discovery.ucl.ac.uk/id/eprint/10166261/1/e066952.full.pdf.  , 2023
 
?
5

Estimation of recurrent atherosclerotic cardiovascular even..:

Hageman, SHJ ; McKay, AJ ; Ueda, P...
https://discovery.ucl.ac.uk/id/eprint/10162271/1/Estimation%20of%20recurrent%20atherosclerotic%20cardiovascular.zip.  , 2022
 
?
6

Risk Stratification in Patients with Ischemic Stroke and Re..:

Gynnild MN ; Hageman SHJ ; Dorresteijn JAN...
https://www.dovepress.com/risk-stratification-in-patients-with-ischemic-stroke-and-residual-card-peer-reviewed-fulltext-article-CLEP.  , 2021
 
?
7

Cardiovascular risk factors and the risk of major adverse l..:

Hageman, SHJ ; De Borst, GJ ; Dorresteijn, JAN...
https://discovery.ucl.ac.uk/id/eprint/10096914/1/Hageman_Manuscript_MALE_20200211_clean.pdf.  , 2020
 
1-7